CN109965281A - A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment - Google Patents
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment Download PDFInfo
- Publication number
- CN109965281A CN109965281A CN201711447496.7A CN201711447496A CN109965281A CN 109965281 A CN109965281 A CN 109965281A CN 201711447496 A CN201711447496 A CN 201711447496A CN 109965281 A CN109965281 A CN 109965281A
- Authority
- CN
- China
- Prior art keywords
- nutrient powder
- parts
- blood glucose
- blood
- equal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 49
- 210000004369 blood Anatomy 0.000 title claims abstract description 49
- 239000000843 powder Substances 0.000 title claims abstract description 47
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 34
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 25
- 239000008103 glucose Substances 0.000 title claims abstract description 25
- 150000002632 lipids Chemical class 0.000 title claims abstract description 18
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 12
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 34
- 241000209219 Hordeum Species 0.000 claims abstract description 30
- 229920001202 Inulin Polymers 0.000 claims abstract description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 229940029339 inulin Drugs 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 11
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 9
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 9
- 240000002853 Nelumbo nucifera Species 0.000 claims description 10
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 10
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 244000075850 Avena orientalis Species 0.000 claims description 8
- 235000007319 Avena orientalis Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- 240000005979 Hordeum vulgare Species 0.000 claims 4
- 240000000249 Morus alba Species 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 17
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 11
- 206010010774 Constipation Diseases 0.000 abstract description 9
- 208000013016 Hypoglycemia Diseases 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000007661 gastrointestinal function Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007413 intestinal health Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010021000 Hypoglycaemic coma Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960001761 chlorpropamide Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to field of food, more particularly to the nutrient powder of a kind of improvement blood glucose, blood lipid and intestinal environment, by weight, nutrient powder includes following components: 25~67 parts of inulin, 25~70 portions of highland barleys, 1~10 part of mulberry-leaf extract, 1~10 part of Bitter Melon P.E, 1~10 part of bitter buckwheat.Its blood glucose that " three high " crowd can be effectively reduced and blood lipid, improve the function of intestinal canal of people, reduce constipation, also it can improve the blood glucose level of hypoglycemia crowd, keep its blood glucose value close to optimum level value, its complication that can also improve its gastrointestinal function variation while improving the blood sugar concentration of diabetes patient, makes the blood glucose level of diabetes patient maintain a stable state.
Description
Technical field
The present invention relates to field of food, and in particular to a kind of nutrient powder for improving blood glucose, blood lipid and intestinal environment.
Background technique
With the development of the social economy, the dietary structure of people is changed, wherein high cholesterol, high confectionery object are accounted for
Than becoming larger, increase hyperglycemia and hyperlipidemia risk, be also easier to cause in other angiocarpy disease and three high crowds also increasingly
Rejuvenation；The variation of people's dietary structure further includes that the accounting of flour and rice increases, and which increases the risks of constipation, furthermore, with life
The quickening that movable joint is played, diet is also more irregular, further compromises the intestinal health of people.Three high and constipation these two types diseases
The quality of life of modern is seriously affected.
Latest survey shows that for Chinese diabetic up to 1.14 hundred million, maturity-onset diabetes Proportion of patients is 9.7%, 60
Year old or more crowd's disease incidence be up to 20.4%, the disease incidence of overweight crowd is up to 18.5%.And gastrointestinal function variation is sugar
The common complication of patient is urinated, including including dysphagia, reflux after feed is had a stomach upset and burn feeling, abdominal distention after meal, abdomen
It rushes down, constipation etc..66% or more diabetes patient has apparent vagus nerve function abnormal, causes gastric secretion to reduce, causes food
It is discharged into duodenum difficulty, slows down enterocinesia, thus is easy constipation.Suffer from the patient of diabetes, constipation person occurs and almost accounts for half.
Meanwhile diabetic during drug therapy, relatively occur diabetes merge Hypoglycemic symptoms, especially taking
With insulin therapy and sulfonylurea drugs, incidence accounts for about 20%, wherein first generation sulfonylurea drugs chlorpropamide most easily draws
Play hypoglycemia.It is light then Hypoglycemic symptoms occur；Hypoglycemic coma occurs for the heavy then disturbance of consciousness.
Existing drug only has the function of single on the market, cannot realize hypoglycemic simultaneously and improve the effect of intestinal health
Fruit, and it is also accompanied by the side effect of hypoglycemia, it cannot take for a long time.And existing functional food mostly uses crude fibre nutrient powder
Come the effect realized hypoglycemic with improve constipation, but its effect is limited, can reduce blood sugar concentration to a certain extent and reduce constipation,
But blood lipid, blood glucose level and intestinal health cannot be improved.
Summary of the invention
The present invention provides a kind of nutrient powder for improving blood glucose, blood lipid and intestinal health in order to solve the above problem, can be effective
The blood glucose and blood lipid for reducing " three high " crowd improve the function of intestinal canal of people, reduce constipation, can also improve the blood of hypoglycemia crowd
Sugar level keeps its blood glucose value close to optimum level value, can also improve it while improving the blood sugar concentration of diabetes patient
The complication that gastrointestinal function is deteriorated, makes the blood glucose level of diabetes patient maintain a stable state.
For achieving the above object, technical scheme is as follows:
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment, which is characterized in that by weight, including following components:
25~67 parts of inulin, 25~70 portions of highland barleys, 1~10 part of mulberry-leaf extract, 1~10 part of Bitter Melon P.E, 1~10 part of bitter buckwheat.
Further, by weight, the nutrient powder further includes 5~20 parts of oat brans.
Further, by weight, the nutrient powder further includes 1~10 part of Lotus Leafextract.
Further, the nutrient powder is by 20 parts of inulin, 60 portions of highland barleys, 2 parts of mulberry-leaf extracts, 2 parts of Bitter Melon P.Es, 2
Part bitter buckwheat, 5 parts of xylitols, 7 points of oat brans and 2 parts of Lotus Leafextracts compositions.
Further, the content of the inulin is greater than or equal to 90%, and the degree of polymerization is more than or equal to 2 and less than or equal to 30,
Solubility is greater than or equal to 99%.
Further, the highland barley refers to the full powder of highland barley, is prepared by the following method: by the high-quality blueness in the Tibet region of buying
Highland barley dries after screening, cleaning, again by highland barley toast it is ripe after, wear into 80~100 mesh fine powders, stand-by.
The beneficial effects of the present invention are:
1. enabling nutrient powder hypoglycemic provided by the invention, lipid-loweringing, moreover it is possible to be effectively improved three high people due to using inulin
The stomach health of group or diabetes patient, while can also improve the blood glucose level of hypoglycemia crowd；The a small amount of 2-9 contained in inulin is low
Fructooligosaccharides can be such that the expression of brain nervous cell trophic factors increases, and have good protection to the neuron harm of cortisone induction
Effect has good antidepressant effect, can reduce the negative factor of patient's diabetic spirit aspect.
2. due to the full powder of high-quality highland barley for using Tibet region, wherein beta glucan rich in, further enhances
The effect of lipid-loweringing of the present invention and hypoglycemic.
3. due to using Lotus Leafextract, the compatibility of Lotus Leafextract, balsam pear and mulberry-leaf extract substantially increases three
The effect of person's hypoglycemic and lipid-loweringing.
4. keeping lipid-loweringing of the invention, hypoglycemic effect more excellent due to using the higher oat bran of beta glucan content
It is different.
Specific embodiment
The present invention is further illustrated with reference to embodiments.
Embodiment 1
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment, the nutrient powder is by 20 parts of inulin, 60 portions of highland barleys, 2 parts
Mulberry-leaf extract, 2 parts of Bitter Melon P.Es, 2 parts of bitter buckwheats, 5 parts of xylitols, 7 points of oat brans and 2 parts of Lotus Leafextract compositions；Wherein,
The content of inulin is greater than or equal to 90%, and the degree of polymerization is more than or equal to 2 and less than or equal to 30, and solubility is greater than or equal to 99%；
Highland barley refers to the full powder of highland barley, is prepared by the following method: the high-quality highland barley in the Tibet region of buying is got rid of after screening, cleaning
It is dry, again by highland barley toast it is ripe after, wear into 80~100 mesh fine powders, stand-by；Other components purchase the segmented industry belonging to the whole nation certainly
The product of leading enterprise.
Embodiment 2
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment, the nutrient powder is by 67 parts of inulin, 25 portions of highland barleys, 2 parts
Mulberry-leaf extract, 2 parts of Bitter Melon P.Es, 2 parts of bitter buckwheats, 5 parts of xylitols, 20 points of oat brans and 2 parts of Lotus Leafextract compositions；Its
In, the content of inulin is greater than or equal to 90%, and the degree of polymerization is more than or equal to 2 and less than or equal to 30, and solubility is greater than or equal to
99%；Highland barley refers to the full powder of highland barley, is prepared by the following method: by the high-quality highland barley in the Tibet region of buying by screening, cleaning
Afterwards drying, again by highland barley toast it is ripe after, wear into 80~100 mesh fine powders, stand-by；Other components are purchased from the affiliated subdivision row in the whole nation
The product of the leading enterprise of industry.
Embodiment 3
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment, the nutrient powder is by 25 parts of inulin, 60 parts of highland barleys, 10
Part mulberry-leaf extract, 10 parts of Bitter Melon P.Es, 10 parts of bitter buckwheats, 5 parts of xylitols, 5 points of oat brans and 10 parts of Lotus Leafextracts compositions；
Wherein, the content of inulin is greater than or equal to 90%, and the degree of polymerization is more than or equal to 2 and less than or equal to 30, and solubility is greater than or equal to
99%；Highland barley refers to the full powder of highland barley, is prepared by the following method: by the high-quality highland barley in the Tibet region of buying by screening, cleaning
Afterwards drying, again by highland barley toast it is ripe after, wear into 80~100 mesh fine powders, stand-by；Other components are purchased from the affiliated subdivision row in the whole nation
The product of the leading enterprise of industry.
Embodiment 4
A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment, the nutrient powder is by 40 parts of inulin, 40 portions of highland barleys, 5 parts
Mulberry-leaf extract, 5 parts of Bitter Melon P.Es, 5 parts of bitter buckwheats, 5 parts of xylitols, 20 points of oat brans and 5 parts of Lotus Leafextract compositions；Its
In, the content of inulin is greater than or equal to 90%, and the degree of polymerization is more than or equal to 2 and less than or equal to 30, and solubility is greater than or equal to
99%；Highland barley refers to the full powder of highland barley, is prepared by the following method: by the high-quality highland barley in the Tibet region of buying by screening, cleaning
Afterwards drying, again by highland barley toast it is ripe after, wear into 80~100 mesh fine powders, stand-by；Other components are purchased from the affiliated subdivision row in the whole nation
The product of the leading enterprise of industry.
100 consumers are selected to carry out comprehensive acceptance degree to the nutrient powder in above-described embodiment.Comprehensive acceptance is specific
Refer to the sensory effects evaluation to the appearance and mouthfeel of product, wherein the calculation formula of comprehensive acceptance is as follows: comprehensive acceptance
=[being satisfied with number/total number of persons] × 100%.
Table 1 integrates acceptance test data
50 people are selected to try out respectively the nutrient powder of above-described embodiment 1-4, the trial period is 3 months, is divided into for 3 phases, often
Phase 30 days, above-mentioned nutrient powder 10g is used daily, and the blood glucose and blood lipid to crowd on probation carry out tracking and testing.In each embodiment
Experimenter's group's composition is identical, and crowd's composition on probation is shown in Table 2, and hypoglycemic effect is shown in Table 3.Wherein efficient calculation formula is as follows:
Effective percentage=[efficiently individual quantity/total number of persons] × 100%, blood glucose improve efficient: hyperglycemia population blood glucose reduces, hypoglycemia crowd
Blood sugar recovery is close to best blood glucose value (international standard empty stomach 5.6)；Blood fat and improving is efficient: people with hyperlipidemia lipids detection index
Decline.
Table 2 experimenter group's composition
Nutrient powder in each embodiment of table 3 improves the effect of blood glucose, blood lipid
As shown in Table 3, nutrient powder of the present invention is tried out, the level of blood sugar for human body and blood lipid can be obviously improved, respectively
Hypoglycemic highest level in embodiment is up to 89%, and for lipid-loweringing highest level up to 90%, the effective percentage for adjusting hypoglycemia is reachable
92%.
The present invention effectively overcomes various shortcoming in the prior art and has high industrial utilization value.Above-described embodiment is only
The principle of the present invention and its effect is illustrated, and is not intended to limit the present invention.Any person skilled in the art all can be
Without prejudice under spirit and scope of the invention, carry out modifications and changes to above-described embodiment.Therefore, such as in technical field
All equivalent modifications or change that tool usually intellectual is completed without departing from the spirit and technical ideas disclosed in the present invention
Become, should be covered by the claims of the present invention.
Claims (6)
1. a kind of nutrient powder for improving blood glucose, blood lipid and intestinal environment, which is characterized in that by weight, including following components: 25
~67 parts of inulin, 25~70 portions of highland barleys, 1~10 part of mulberry-leaf extract, 1~10 part of Bitter Melon P.E, 1~10 part of bitter buckwheat.
2. nutrient powder as described in claim 1, which is characterized in that by weight, the nutrient powder further includes 5~20 portions of oats
Bran.
3. nutrient powder as claimed in claim 1 or 2, which is characterized in that by weight, the nutrient powder further includes 1~10 portion of lotus
Leaf extract.
4. nutrient powder as claimed in claim 3, which is characterized in that the nutrient powder is by 20 parts of inulin, 60 portions of highland barleys, 2 parts of mulberry leaf
Extract, 2 parts of Bitter Melon P.Es, 2 parts of bitter buckwheats, 5 parts of xylitols, 7 points of oat brans and 2 parts of Lotus Leafextract compositions.
5. the nutrient powder as described in claim any one of 1-4, which is characterized in that the content of the inulin is greater than or equal to 90%,
Its degree of polymerization is more than or equal to 2 and less than or equal to 30, and solubility is greater than or equal to 99%.
6. the nutrient powder as described in claim any one of 1-4, which is characterized in that the highland barley refers to the full powder of highland barley, by following
Method preparation: the high-quality highland barley in the Tibet region of buying is dried after screening, cleaning, again by highland barley toast it is ripe after, wear into 80
It is~100 mesh fine powders, stand-by.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711447496.7A CN109965281A (en) | 2017-12-27 | 2017-12-27 | A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711447496.7A CN109965281A (en) | 2017-12-27 | 2017-12-27 | A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109965281A true CN109965281A (en) | 2019-07-05 |
Family
ID=67071170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711447496.7A Pending CN109965281A (en) | 2017-12-27 | 2017-12-27 | A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109965281A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110623266A (en) * | 2019-10-18 | 2019-12-31 | 兰州奇正生态健康品有限公司 | Health food for assisting in reducing blood sugar and preparation method thereof |
| CN112655853A (en) * | 2019-09-30 | 2021-04-16 | 中粮营养健康研究院有限公司 | Highland barley solid beverage, preparation method thereof and application thereof in preparing product for regulating blood sugar |
| CN113892636A (en) * | 2021-09-17 | 2022-01-07 | 江苏米疗生物科技有限公司 | Snack with blood sugar reducing effect and preparation method thereof |
| CN115176993A (en) * | 2022-07-15 | 2022-10-14 | 四川慢糖生物科技有限公司 | Carbohydrate formula capable of slowly releasing and stabilizing blood sugar balance |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105010976A (en) * | 2015-08-03 | 2015-11-04 | 重庆赛福食品有限公司 | Nutrition powder capable of losing weight and lowering blood glucose and preparation method of nutrition powder |
| CN105815625A (en) * | 2015-01-08 | 2016-08-03 | 杨淑珍 | Health food for adjusting blood sugar and preparation method thereof |
| CN106343570A (en) * | 2016-11-07 | 2017-01-25 | 胡松茂 | Sugar absorption-restraining and controlling instant formula grain powder for special diet of diabetes |
-
2017
- 2017-12-27 CN CN201711447496.7A patent/CN109965281A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105815625A (en) * | 2015-01-08 | 2016-08-03 | 杨淑珍 | Health food for adjusting blood sugar and preparation method thereof |
| CN105010976A (en) * | 2015-08-03 | 2015-11-04 | 重庆赛福食品有限公司 | Nutrition powder capable of losing weight and lowering blood glucose and preparation method of nutrition powder |
| CN106343570A (en) * | 2016-11-07 | 2017-01-25 | 胡松茂 | Sugar absorption-restraining and controlling instant formula grain powder for special diet of diabetes |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112655853A (en) * | 2019-09-30 | 2021-04-16 | 中粮营养健康研究院有限公司 | Highland barley solid beverage, preparation method thereof and application thereof in preparing product for regulating blood sugar |
| CN110623266A (en) * | 2019-10-18 | 2019-12-31 | 兰州奇正生态健康品有限公司 | Health food for assisting in reducing blood sugar and preparation method thereof |
| CN113892636A (en) * | 2021-09-17 | 2022-01-07 | 江苏米疗生物科技有限公司 | Snack with blood sugar reducing effect and preparation method thereof |
| CN115176993A (en) * | 2022-07-15 | 2022-10-14 | 四川慢糖生物科技有限公司 | Carbohydrate formula capable of slowly releasing and stabilizing blood sugar balance |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thondre et al. | High-molecular-weight barley β-glucan in chapatis (unleavened Indian flatbread) lowers glycemic index | |
| Roberts | High–glycemic index foods, hunger, and obesity: is there a connection? | |
| CN109965281A (en) | A kind of nutrient powder improving blood glucose, blood lipid and intestinal environment | |
| CN102187887B (en) | Sandwich biscuit with functions of losing weight and regulating blood sugar and production method thereof | |
| Chillo et al. | Glycemic response and glycemic index of semolina spaghetti enriched with barley β-glucan | |
| Karalus et al. | Fermentable fibers do not affect satiety or food intake by women who do not practice restrained eating | |
| CN108112996A (en) | A kind of alimentation composition for controlling diabetes B crowd hyperglycaemia and improving immunity | |
| CN106172890A (en) | A kind of fat-reducing oils and fats and using method thereof | |
| CN106360310A (en) | Composition for dropping after meal blood sugar and application thereof | |
| Hamad et al. | Parboiled rice metabolism differs in healthy and diabetic individuals with similar improvement in glycemic response | |
| Schenker | An overview of the role of rice in the UK diet | |
| Bajerska et al. | Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study | |
| CN106858621B (en) | A kind of diet fiber composition and preparation method thereof adjusting blood pressure and blood lipoid | |
| Tucker et al. | Effects of breads of varying carbohydrate quality on postprandial glycaemic, incretin and lipidaemic response after first and second meals in adults with diet-controlled type 2 diabetes | |
| Aldughpassi et al. | Effect of psyllium fiber addition on the quality of Arabic flatbread (Pita) produced in a commercial bakery | |
| Mohebbi et al. | The effects of prebiotic bread containing oat ß-glucan and resistant starch on the glycemic index and glycemic load in healthy individuals | |
| CN104642884A (en) | Staple wheat flour and staple rice for diabetics | |
| Chen et al. | Evaluation of white sweet potato tube-feeding formula in elderly diabetic patients: a randomized controlled trial | |
| Almaski et al. | Millet intake and risk factors of type 2 diabetes: A systematic review | |
| Agrawal et al. | Managing diabetes mellitus with millets: A new solution | |
| ES2892900T3 (en) | Glycemic lowering composition | |
| Sobhana et al. | Development of low glycemic index rice and its effectiveness in the regulation of postprandial glucose response in type 2 diabetes | |
| EP2294932B1 (en) | Carbohydrate mixture and the use thereof for preparing a product for oral or enteral nutrition | |
| CN103564091A (en) | Formula, manufacturing technology and applications of green bonnie scented tea | |
| US20060280681A1 (en) | Food for testing life style-related diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190705 |
|
| RJ01 | Rejection of invention patent application after publication |